Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for neuromyelitis optica spectrum disorder without anti-MOG and without anti-AQP4 antibodies has been reported in the published literature.
No clinical trials have been registered for neuromyelitis optica spectrum disorder without anti-MOG and without anti-AQP4 antibodies.
11 publications have been identified in PubMed for neuromyelitis optica spectrum disorder without anti-MOG and without anti-AQP4 antibodies. Research spans Epidemiology / Natural History (45%), Case Report / Case Series (36%), and Diagnostic / Biomarker (9%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 5 |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 9:52 PM UTC
Program availability and eligibility requirements are set by each foundation. Contact them directly to learn more about your options.
Claim this page and your organization will be listed here for patients and families to find.
European rare disease database
Genetic and Rare Diseases Info Center
Patient case studies | 4 | 36% |
Testing and diagnosis research | 1 | 9% |
Research summaries | 1 | 9% |
Jang Y (2026). [PMID: 41870402](https://pubmed.ncbi.nlm.nih.gov/41870402/). *Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society*. [Epidemiology / Natural History]
Alfonso-Cedeño DF (2026). [PMID: 41619449](https://pubmed.ncbi.nlm.nih.gov/41619449/). *Journal of neuroimmunology*. [Review / Meta-Analysis]
Romano G (2025). [PMID: 41225357](https://pubmed.ncbi.nlm.nih.gov/41225357/). *BMC neurology*. [Case Report / Case Series]
Taha SI (2025). [PMID: 39789036](https://pubmed.ncbi.nlm.nih.gov/39789036/). *Scientific reports*. [Epidemiology / Natural History]
Samadzadeh S (2025). [PMID: 40485599](https://pubmed.ncbi.nlm.nih.gov/40485599/). *European journal of neurology*. [Epidemiology / Natural History]
Jączak-Goździak M (2025). [PMID: 40137458](https://pubmed.ncbi.nlm.nih.gov/40137458/). *Neurology international*. [Case Report / Case Series]
Nishino S (2025). [PMID: 40506104](https://pubmed.ncbi.nlm.nih.gov/40506104/). *BMJ case reports*. [Case Report / Case Series]
Cao Y (2024). [PMID: 39238786](https://pubmed.ncbi.nlm.nih.gov/39238786/). *Frontiers in genetics*. [Diagnostic / Biomarker]
Al Jassem O (2024). [PMID: 39219777](https://pubmed.ncbi.nlm.nih.gov/39219777/). *Clinical case reports*. [Case Report / Case Series]
Lopes J (2024). [PMID: 39236487](https://pubmed.ncbi.nlm.nih.gov/39236487/). *Multiple sclerosis and related disorders*. [Epidemiology / Natural History]
AI-curated news mentioning neuromyelitis optica spectrum disorder without anti-MOG and without anti-AQP4 antibodies
Updated Jan 4, 2023
A singer with neuromyelitis optica spectrum disorder (NMOSD) shares her journey to raise awareness and advocate for accurate diagnosis. Her story highlights the importance of patient voices in the rare disease community.